Improving treatment with methotrexate in rheumatoid arthritis-Development of a multimedia patient education program and the MiRAK, a new instrument to evaluate methotrexate-related knowledge

We developed a MPEP about MTX treatment for RA, which was found to be user-friendly and easily implementable. The MiRAK is a new scale, testing a broad spectrum of MTX knowledge. Analyses revealed strong evidence for its validity and reliability.